Genome-Wide Epigenetic Landscape of Lung Adenocarcinoma Links HOXB9 DNA Methylation to Intrinsic EGFR-TKI Resistance and Heterogeneous Responses

PURPOSE: Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) show efficacy in treating patients with lung adenocarcinoma with EGFR-activating mutations. However, a significant subset of targeted patients fail to respond. Unlike acquired resistance (AR), intrinsic resistance (IR...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Sheng-Fang, Liu, Chia-Hsin, Cheng, Chiou-Ling, Ho, Chao-Chi, Yang, Tsung-Ying, Chen, Kun-Chieh, Hsu, Kuo-Hsuan, Tseng, Jeng-Sen, Chen, Huei-Wen, Chang, Gee-Chen, Yu, Sung-Liang, Li, Ker-Chau
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2021
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140798/
https://www.ncbi.nlm.nih.gov/pubmed/34036228
http://dx.doi.org/10.1200/PO.20.00151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140798/
https://www.ncbi.nlm.nih.gov/pubmed/34036228
http://dx.doi.org/10.1200/PO.20.00151

Ejemplares similares